Michael R Sargen, Madeline H Fitzhugh, Jennifer S Ko, Allison G Close, Sara C Horton, Faizan Malik, Larissa V Furtado, Armita Bahrami, Brittani K N Seynnaeve, Alberto S Pappo, Vincent Liu, Kevin Cheung, Svetlana D Pack, Liqiang Xi, Mark Raffeld, Ina Lee, Jeffrey Gagan, Kenneth Aldape, Frederic G Barr, Stephen M Hewitt, Christina K Ferrone, Anna Hayden, Jessica N Hatton, Alisa M Goldstein, Ruth M Pfeiffer, Brigitte Widemann, Mary Frances Wedekind Malone, Andrea M Gross, Rosandra Kaplan, Marielle E Yohe, Kristen G Berrebi
{"title":"Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series.","authors":"Michael R Sargen, Madeline H Fitzhugh, Jennifer S Ko, Allison G Close, Sara C Horton, Faizan Malik, Larissa V Furtado, Armita Bahrami, Brittani K N Seynnaeve, Alberto S Pappo, Vincent Liu, Kevin Cheung, Svetlana D Pack, Liqiang Xi, Mark Raffeld, Ina Lee, Jeffrey Gagan, Kenneth Aldape, Frederic G Barr, Stephen M Hewitt, Christina K Ferrone, Anna Hayden, Jessica N Hatton, Alisa M Goldstein, Ruth M Pfeiffer, Brigitte Widemann, Mary Frances Wedekind Malone, Andrea M Gross, Rosandra Kaplan, Marielle E Yohe, Kristen G Berrebi","doi":"10.1002/pbc.31814","DOIUrl":null,"url":null,"abstract":"<p><p>Limited information is available on the clinicopathologic features and management of pediatric CRTC1::TRIM11 (CTRTs) and MED15::ATF1-rearranged tumors (MARTs). In this series of pediatric CTRTs (n = 5) and MARTs (n = 2), all tumors exhibited spitzoid morphology and expressed melanocytic markers. Metastatic progression occurred in one CTRT and two MARTs: all three received immunotherapy, resulting in disease control in two patients and one death due to progressive disease. A fourth individual had lymph node micrometastasis that remained stable without progression. This case series highlights the potentially aggressive behavior of these tumors and suggests that immunotherapy may be an effective treatment option for advanced disease.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e31814"},"PeriodicalIF":2.4000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pbc.31814","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Limited information is available on the clinicopathologic features and management of pediatric CRTC1::TRIM11 (CTRTs) and MED15::ATF1-rearranged tumors (MARTs). In this series of pediatric CTRTs (n = 5) and MARTs (n = 2), all tumors exhibited spitzoid morphology and expressed melanocytic markers. Metastatic progression occurred in one CTRT and two MARTs: all three received immunotherapy, resulting in disease control in two patients and one death due to progressive disease. A fourth individual had lymph node micrometastasis that remained stable without progression. This case series highlights the potentially aggressive behavior of these tumors and suggests that immunotherapy may be an effective treatment option for advanced disease.
期刊介绍:
Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.